Teva Pharmaceuticals USA recalls Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg 30 tablets per Bottle, Rx only, Distributed By: Teva Pharmaceuti
Recalled July 26, 2017 · FDA recall D-0984-2017 · Teva Pharmaceuticals USA
Hazard
Failed Impurities/Degradation Specifications: out of specification test results for related compounds largest unknown impurity. · FDA Class III
Units
196275 bottles
Sold at
Nationwide in the USA
Description
Failed Impurities/Degradation Specifications: out of specification test results for related compounds largest unknown impurity.
Product
Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg 30 tablets per Bottle, Rx only, Distributed By: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-5721-56
Manufacturer(s)
Teva Pharmaceuticals USA
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →